
The PSMA PET radiopharmaceutical 64Cu-SAR-bisPSMA, which previously garnered two FDA fast track designations, more than doubled the detection of PCa lesions in comparison to 68Ga-PSMA-11 in the phase II Co-PSMA trial.
Diagnostic Imaging spoke with Elad Benjamin, Vice President for Radiology Informatics at Philips Healthcare, about his thoughts on trends at RSNA 2019, as well as the recent integration with Carestream.






